methamphetamine has been researched along with rasagiline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Commissiong, JW; Finberg, JP; Johnston, JM; Takeshima, T | 1 |
| Abassi, ZA; Binah, O; Youdim, MB | 1 |
| Grasing, K; He, S | 1 |
| Blaugrund, E; Cohen, S; Eliash, S; Fine, T; Litinetsky, L; Speiser, Z | 1 |
| Dimpfel, W; Hoffmann, JA; Müller, T; Oehlwein, C | 1 |
| Kakish, J; Lee, JS; Tavassoly, O | 1 |
| Choi, S; Graves, SM; Methiwala, HN | 1 |
1 review(s) available for methamphetamine and rasagiline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for methamphetamine and rasagiline
| Article | Year |
|---|---|
Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor.
Topics: Animals; Cell Survival; Cells, Cultured; Clorgyline; Dopamine; Embryo, Mammalian; gamma-Aminobutyric Acid; Indans; Mesencephalon; Methamphetamine; Microtubule-Associated Proteins; Monoamine Oxidase Inhibitors; Neurons; Rats; Rats, Sprague-Dawley; Selegiline; Tyrosine 3-Monooxygenase | 1998 |
Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline.
Topics: Administration, Oral; Animals; Blood Flow Velocity; Blood Pressure; Cardiovascular Physiological Phenomena; Carotid Arteries; Indans; Injections, Intravenous; Methamphetamine; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selegiline; Time Factors; Vascular Resistance | 2004 |
L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
Topics: Animals; Behavior, Animal; Body Weight; Central Nervous System Stimulants; Clorgyline; Conditioning, Operant; Extinction, Psychological; Indans; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Morphine; Morphine Dependence; Rats; Rats, Wistar; Reinforcement, Psychology; Selegiline; Self Administration; Substance Withdrawal Syndrome | 2006 |
Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline.
Topics: Animals; Behavior, Animal; Brain; Drug Therapy, Combination; Fluoxetine; Indans; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Syndrome | 2008 |
Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease.
Topics: Aged; Amphetamine; Antiparkinson Agents; Drug Substitution; Female; Humans; Indans; Male; Methamphetamine; Middle Aged; Motor Activity; Neuroprotective Agents; Parkinson Disease; Selegiline; Severity of Illness Index; Time Factors | 2013 |
Rasagiline, a suicide inhibitor of monoamine oxidases, binds reversibly to α-synuclein.
Topics: alpha-Synuclein; Calorimetry; Indans; Methamphetamine; Monoamine Oxidase Inhibitors; Nanopores; Neuroprotective Agents; Protein Binding; Selegiline | 2015 |
Isradipine, an L-type calcium channel inhibitor, attenuates cue-associated methamphetamine-seeking in mice.
Topics: Animals; Calcium Channels, L-Type; Central Nervous System Stimulants; Cues; Drug-Seeking Behavior; Female; Isradipine; Male; Methamphetamine; Mice; Self Administration | 2023 |